216 related articles for article (PubMed ID: 25041314)
1. Characterization of acid and non-acid glycosphingolipids of porcine heart valve cusps as potential immune targets in biological heart valve grafts.
Barone A; Benktander J; Teneberg S; Breimer ME
Xenotransplantation; 2014; 21(6):510-22. PubMed ID: 25041314
[TBL] [Abstract][Full Text] [Related]
2. Glycosphingolipids of porcine, bovine, and equine pericardia as potential immune targets in bioprosthetic heart valve grafts.
Barone A; Benktander J; Whiddon C; Jin C; Galli C; Teneberg S; Breimer ME
Xenotransplantation; 2018 Sep; 25(5):e12406. PubMed ID: 29932253
[TBL] [Abstract][Full Text] [Related]
3. Commentary on "Characterization of acid and non-acid glycosphingolipids of porcine heart valve cusps as potential immune targets in biological heart valve grafts" (by Barone et al.): bioprosthetic products from animal origin are xenotransplantation products with their own regulatory path.
Schuurman HJ
Xenotransplantation; 2014; 21(6):507-9. PubMed ID: 25491278
[No Abstract] [Full Text] [Related]
4. Characterization of immunogenic Neu5Gc in bioprosthetic heart valves.
Reuven EM; Leviatan Ben-Arye S; Marshanski T; Breimer ME; Yu H; Fellah-Hebia I; Roussel JC; Costa C; Galiñanes M; Mañez R; Le Tourneau T; Soulillou JP; Cozzi E; Chen X; Padler-Karavani V
Xenotransplantation; 2016 Sep; 23(5):381-92. PubMed ID: 27610947
[TBL] [Abstract][Full Text] [Related]
5. Human antibody recognition of xenogeneic antigens (NeuGc and Gal) on porcine heart valves: could genetically modified pig heart valves reduce structural valve deterioration?
Lee W; Long C; Ramsoondar J; Ayares D; Cooper DK; Manji RA; Hara H
Xenotransplantation; 2016 Sep; 23(5):370-80. PubMed ID: 27511593
[TBL] [Abstract][Full Text] [Related]
6. Xenoantigenicity of porcine decellularized valves.
Helder MRK; Stoyles NJ; Tefft BJ; Hennessy RS; Hennessy RRC; Dyer R; Witt T; Simari RD; Lerman A
J Cardiothorac Surg; 2017 Jul; 12(1):56. PubMed ID: 28716099
[TBL] [Abstract][Full Text] [Related]
7. Expression of NeuGc on pig heart valves.
Lee W; Hara H; Cooper DK; Manji RA
Xenotransplantation; 2015; 22(2):153-4. PubMed ID: 25753748
[No Abstract] [Full Text] [Related]
8. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration.
Simionescu DT; Lovekamp JJ; Vyavahare NR
J Heart Valve Dis; 2003 Mar; 12(2):217-25. PubMed ID: 12701795
[TBL] [Abstract][Full Text] [Related]
9. Elimination of alpha-gal xenoreactive epitope: alpha-galactosidase treatment of porcine heart valves.
Choi SY; Jeong HJ; Lim HG; Park SS; Kim SH; Kim YJ
J Heart Valve Dis; 2012 May; 21(3):387-97. PubMed ID: 22808845
[TBL] [Abstract][Full Text] [Related]
10. Reducing immunoreactivity of porcine bioprosthetic heart valves by genetically-deleting three major glycan antigens, GGTA1/β4GalNT2/CMAH.
Zhang R; Wang Y; Chen L; Wang R; Li C; Li X; Fang B; Ren X; Ruan M; Liu J; Xiong Q; Zhang L; Jin Y; Zhang M; Liu X; Li L; Chen Q; Pan D; Li R; Cooper DKC; Yang H; Dai Y
Acta Biomater; 2018 May; 72():196-205. PubMed ID: 29631050
[TBL] [Abstract][Full Text] [Related]
11. First quantification of alpha-Gal epitope in current glutaraldehyde-fixed heart valve bioprostheses.
Naso F; Gandaglia A; Bottio T; Tarzia V; Nottle MB; d'Apice AJ; Cowan PJ; Cozzi E; Galli C; Lagutina I; Lazzari G; Iop L; Spina M; Gerosa G
Xenotransplantation; 2013; 20(4):252-61. PubMed ID: 23865597
[TBL] [Abstract][Full Text] [Related]
12. A comparison of macroscopic lipid content within porcine pulmonary and aortic valves. Implications for bioprosthetic valves.
Dunmore-Buyze J; Boughner DR; Macris N; Vesely I
J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1756-61. PubMed ID: 8523888
[TBL] [Abstract][Full Text] [Related]
13. Gal-knockout bioprostheses exhibit less immune stimulation compared to standard biological heart valves.
McGregor CG; Kogelberg H; Vlasin M; Byrne GW
J Heart Valve Dis; 2013 May; 22(3):383-90. PubMed ID: 24151765
[TBL] [Abstract][Full Text] [Related]
14. The influence of stenting on the behavior of amino-oleic acid-treated, glutaraldehyde-fixed porcine aortic valves in a sheep model.
Ozaki S; Herijgers P; Verbeken E; Van Lommel A; Nishida T; Perek B; Zietkiewicz M; Leunens V; Flameng W
J Heart Valve Dis; 2000 Jul; 9(4):552-9; discussion 559-60. PubMed ID: 10947049
[TBL] [Abstract][Full Text] [Related]
15. Degeneration of bioprosthetic heart valve cusp and wall tissues is initiated during tissue preparation: an ultrastructural study.
Simionescu DT; Lovekamp JJ; Vyavahare NR
J Heart Valve Dis; 2003 Mar; 12(2):226-34. PubMed ID: 12701796
[TBL] [Abstract][Full Text] [Related]
16. Porcine bioprosthetic heart valves: The next generation.
Manji RA; Menkis AH; Ekser B; Cooper DK
Am Heart J; 2012 Aug; 164(2):177-85. PubMed ID: 22877802
[TBL] [Abstract][Full Text] [Related]
17. Characterization of moose intestinal glycosphingolipids.
Johansson MM; Dedic B; Lundholm K; Branzell FB; Barone A; Benktander J; Teneberg S
Glycoconj J; 2015 Aug; 32(6):393-412. PubMed ID: 26104834
[TBL] [Abstract][Full Text] [Related]
18. Are N-glycolylneuraminic acid (Hanganutziu-Deicher) antigens important in pig-to-human xenotransplantation?
Miwa Y; Kobayashi T; Nagasaka T; Liu D; Yu M; Yokoyama I; Suzuki A; Nakao A
Xenotransplantation; 2004 May; 11(3):247-53. PubMed ID: 15099204
[TBL] [Abstract][Full Text] [Related]
19. Biaxial strain distributions in explanted porcine bioprosthetic valves.
Adamczyk MM; Vesely I
J Heart Valve Dis; 2002 Sep; 11(5):688-95. PubMed ID: 12358406
[TBL] [Abstract][Full Text] [Related]
20. Physical equivalency of wild type and galactose α 1,3 galactose free porcine pericardium; a new source material for bioprosthetic heart valves.
McGregor C; Byrne G; Rahmani B; Chisari E; Kyriakopoulou K; Burriesci G
Acta Biomater; 2016 Sep; 41():204-209. PubMed ID: 27268480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
